Search Page

1

Cite

Share

Monogenic Causes of Proteinuria in Children.

Cil O, Perwad F. Cil O, et al. Front Med (Lausanne). 2018 Mar 12;5:55. doi: 10.3389/fmed.2018.00055. eCollection 2018. Front Med (Lausanne). 2018. PMID: 29594119 Free PMC article. Review.

Cite

Share

2

Cite

Share

Small-molecule inhibitors of urea transporters.

Verkman AS, Esteva-Font C, Cil O, Anderson MO, Li F, Li M, Lei T, Ren H, Yang B. Verkman AS, et al. Among authors: cil o. Subcell Biochem. 2014;73:165-77. doi: 10.1007/978-94-017-9343-8_11. Subcell Biochem. 2014. PMID: 25298345 Free PMC article. Review.

Cite

Share

3

Cite

Share

The effect of fibromyalgia treatment on tinnitus.

Cil ÖÇ, Zateri C, Güçlü O, Oymak S, Tezcan E. Cil ÖÇ, et al. Am J Otolaryngol. 2020 May-Jun;41(3):102390. doi: 10.1016/j.amjoto.2020.102390. Epub 2020 Jan 3. Am J Otolaryngol. 2020. PMID: 31926598

Cite

Share

4

Cite

Share

Repurposing calcium-sensing receptor agonist cinacalcet for treatment of CFTR-mediated secretory diarrheas.

Oak AA, Chhetri PD, Rivera AA, Verkman AS, Cil O. Oak AA, et al. Among authors: cil o. JCI Insight. 2021 Feb 22;6(4):e146823. doi: 10.1172/jci.insight.146823. JCI Insight. 2021. PMID: 33400691 Free PMC article.

Cite

Share

5

Cite

Share

Olfactory dysfunction may predict myocardial injury in COVID-19 patients.

Akşit E, Çil ÖÇ, Kaya H. Akşit E, et al. Among authors: cil oc. Med Hypotheses. 2020 Nov;144:110232. doi: 10.1016/j.mehy.2020.110232. Epub 2020 Sep 2. Med Hypotheses. 2020. PMID: 33254539 Free PMC article. No abstract available.

Cite

Share

6

Cite

Share

Olfactory Dysfunction in Patients with Ischemic Heart Failure.

Akşıt E, Çıl ÖÇ. Akşıt E, et al. Among authors: cil oc. Acta Cardiol Sin. 2020 Mar;36(2):133-139. doi: 10.6515/ACS.202003_36(2).20190812B. Acta Cardiol Sin. 2020. PMID: 32201464 Free PMC article.

Cite

Share

7

Cite

Share

Inhibition of CFTR-mediated intestinal chloride secretion as potential therapy for bile acid diarrhea.

Duan T, Cil O, Tse CM, Sarker R, Lin R, Donowitz M, Verkman AS. Duan T, et al. Among authors: cil o. FASEB J. 2019 Oct;33(10):10924-10934. doi: 10.1096/fj.201901166R. Epub 2019 Jul 3. FASEB J. 2019. PMID: 31268738 Free PMC article.

Cite

Share

8

Cite

Share

Nanomolar-Potency 1,2,4-Triazoloquinoxaline Inhibitors of the Kidney Urea Transporter UT-A1.

Lee S, Cil O, Diez-Cecilia E, Anderson MO, Verkman AS. Lee S, et al. Among authors: cil o. J Med Chem. 2018 Apr 12;61(7):3209-3217. doi: 10.1021/acs.jmedchem.8b00343. Epub 2018 Apr 3. J Med Chem. 2018. PMID: 29589443 Free PMC article.

Cite

Share

9

Cite

Share

Slowed gastric emptying and improved oral glucose tolerance produced by a nanomolar-potency inhibitor of calcium-activated chloride channel TMEM16A.

Cil O, Anderson MO, Yen R, Kelleher B, Huynh TL, Seo Y, Nilsen SP, Turner JR, Verkman AS. Cil O, et al. FASEB J. 2019 Oct;33(10):11247-11257. doi: 10.1096/fj.201900858R. Epub 2019 Jul 12. FASEB J. 2019. PMID: 31299174 Free PMC article.

Cite

Share

10

Cite

Share

A Turkish BCS1L mutation causes GRACILE-like disorder.

Serdaroğlu E, Takcı Ş, Kotarsky H, Çil O, Utine E, Yiğit Ş, Fellman V. Serdaroğlu E, et al. Among authors: cil o. Turk J Pediatr. 2016;58(6):658-661. doi: 10.24953/turkjped.2016.06.013. Turk J Pediatr. 2016. PMID: 29090881 Free article.

Cite

Share